Page last updated: 2024-11-02

pioglitazone and Head and Neck Neoplasms

pioglitazone has been researched along with Head and Neck Neoplasms in 4 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research Excerpts

ExcerptRelevanceReference
"Head and neck cancer is a major source of morbidity and mortality worldwide."2.50PPARγ in head and neck cancer prevention. ( Burotto, M; Szabo, E, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Rosas, RR1
Nachbor, KM1
Handley, N2
Mathison, G1
Wuertz, BR1
Ba'th, F1
Ondrey, FG1
Yang, TH1
Xirasagar, S1
Cheng, YF1
Wu, CS1
Kao, YW1
Shia, BC1
Lin, HC1
Burotto, M1
Szabo, E1
Eide, J1
Taylor, R1
Wuertz, B1
Gaffney, P1
Ondrey, F1

Reviews

1 review available for pioglitazone and Head and Neck Neoplasms

ArticleYear
PPARγ in head and neck cancer prevention.
    Oral oncology, 2014, Volume: 50, Issue:10

    Topics: Clinical Trials as Topic; Disease Progression; Evidence-Based Medicine; Head and Neck Neoplasms; Hum

2014

Other Studies

3 other studies available for pioglitazone and Head and Neck Neoplasms

ArticleYear
Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head & neck, 2022, Volume: 44, Issue:3

    Topics: Bexarotene; Chemoprevention; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Pioglitazone; United

2022
Association between pioglitazone use and head and neck cancer: Population-based case-control study.
    Head & neck, 2020, Volume: 42, Issue:4

    Topics: Case-Control Studies; Head and Neck Neoplasms; Humans; Hypoglycemic Agents; Pioglitazone; Taiwan

2020
PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques.
    The Laryngoscope, 2017, Volume: 127, Issue:4

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Genomic

2017